CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
Christian Mölleken, Maike Ahrens, Anders Schlosser, Julia Dietz, Martin Eisenacher, Helmut E. Meyer, Wolff Schmiegel, Uffe Holmskov, Christoph Sarrazin, Grith Lykke Sorensen, Barbara Sitek, Thilo Bracht
Clin Mol Hepatol. 2019;25(1):42-51.   Published online 2018 November 19    DOI: https://doi.org/10.3350/cmh.2018.0029

Excel Download

Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
Clinical and Molecular Hepatology. 2019;25(1):42-51   Crossref logo
Link1 Link2 Link3

P1-096: Eradication of chronic hepatitis C infection with direct acting antivirals is associated with reduction in fibrosis by Transient Elastography (FibroScan)
Journal of Viral Hepatitis. 2018;25:73-73   Crossref logo
Link1 Link2

How to optimize current therapy in hepatitis C virus genotype 1 patients. Predictors of response to interferon-based therapy with second wave direct acting antivirals
Liver International. 2014;35:18-20   Crossref logo
Link1

New direct-acting antivirals' combination for the treatment of chronic hepatitis C
Liver International. 2011;31:68-77   Crossref logo
Link1

Noninvasive diagnosis of fibrosis in the patients with hepatitis C virus infection treated with direct-acting antivirals
Journal of Hepatology. 2018;68:S547   Crossref logo
Link1 Link2

P1-079: Liver fibrosis regression after HCV treatment with direct acting antivirals in a community-based population
Journal of Viral Hepatitis. 2018;25:63-63   Crossref logo
Link1 Link2

Safety, Tolerability, and Associated Side Effects of Direct- Acting Antivirals
Hepatitis C - From Infection to Cure. 2018;   Crossref logo
Link1

Resistance-Associated Substitutions in Short Duration of Interferon-Free Direct-Acting Antivirals for Hepatitis C
Gastroenterology. 2017;153(3):867   Crossref logo
Link1 Link2

New horizons in hepatitis C antiviral therapy with direct-acting antivirals
Hepatology. 2013;58(1):428-438   Crossref logo
Link1

Interferon plus ribavirin therapy might cause substitutions in the target domain of direct-acting antivirals in patients with hepatitis C virus
Journal of Clinical Virology. 2015;69:235   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.